BioCentury
ARTICLE | Company News

Nordion sales and marketing update

April 2, 2012 7:00 AM UTC

Nordion launched a custom dose feature in Europe and Canada for its TheraSphere microsphere therapy to treat liver cancer. Nordion said the custom doses provide treatment flexibility for physicians and reduce administration time, product waste and radiation exposure. Nordion said it filed for FDA approval of the custom dose feature. ...